Literature DB >> 15870287

Role of epidermal growth factor receptor signaling in RAS-driven melanoma.

Nabeel Bardeesy1, Minjung Kim, Jin Xu, Ryung-Suk Kim, Qiong Shen, Marcus W Bosenberg, Wing H Wong, Lynda Chin.   

Abstract

The identification of essential genetic elements in pathways governing the maintenance of fully established tumors is critical to the development of effective antioncologic agents. Previous studies revealed an essential role for H-RAS(V12G) in melanoma maintenance in an inducible transgenic model. Here, we sought to define the molecular basis for RAS-dependent tumor maintenance through determination of the H-RAS(V12G)-directed transcriptional program and subsequent functional validation of potential signaling surrogates. The extinction of H-RAS(V12G) expression in established tumors was associated with alterations in the expression of proliferative, antiapoptotic, and angiogenic genes, a profile consistent with the observed phenotype of tumor cell proliferative arrest and death and endothelial cell apoptosis during tumor regression. In particular, these melanomas displayed a prominent RAS-dependent regulation of the epidermal growth factor (EGF) family, leading to establishment of an EGF receptor signaling loop. Genetic complementation and interference studies demonstrated that this signaling loop is essential to H-RAS(V12G)-directed tumorigenesis. Thus, this inducible tumor model system permits the identification and validation of alternative points of therapeutic intervention without neutralization of the primary genetic lesion.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15870287      PMCID: PMC1087708          DOI: 10.1128/MCB.25.10.4176-4188.2005

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  64 in total

1.  Stepwise transformation of primary thyroid epithelial cells by a mutant Ha-ras oncogene: an in vitro model of tumor progression.

Authors:  J S Burns; J P Blaydes; P A Wright; L Lemoine; J A Bond; E D Williams; D Wynford-Thomas
Journal:  Mol Carcinog       Date:  1992       Impact factor: 4.784

2.  Two families of GTPases dominate the complex cellular response to IFN-gamma.

Authors:  U Boehm; L Guethlein; T Klamp; K Ozbek; A Schaub; A Fütterer; K Pfeffer; J C Howard
Journal:  J Immunol       Date:  1998-12-15       Impact factor: 5.422

3.  Requirement for Ras in Raf activation is overcome by targeting Raf to the plasma membrane.

Authors:  S J Leevers; H F Paterson; C J Marshall
Journal:  Nature       Date:  1994-06-02       Impact factor: 49.962

4.  Activation of Raf as a result of recruitment to the plasma membrane.

Authors:  D Stokoe; S G Macdonald; K Cadwallader; M Symons; J F Hancock
Journal:  Science       Date:  1994-06-03       Impact factor: 47.728

5.  Inhibition of HMGI-C protein synthesis suppresses retrovirally induced neoplastic transformation of rat thyroid cells.

Authors:  M T Berlingieri; G Manfioletti; M Santoro; A Bandiera; R Visconti; V Giancotti; A Fusco
Journal:  Mol Cell Biol       Date:  1995-03       Impact factor: 4.272

6.  Germline p16 mutations in familial melanoma.

Authors:  C J Hussussian; J P Struewing; A M Goldstein; P A Higgins; D S Ally; M D Sheahan; W H Clark; M A Tucker; N C Dracopoli
Journal:  Nat Genet       Date:  1994-09       Impact factor: 38.330

7.  Mutation and expression of the p53 gene in human malignant melanoma.

Authors:  A P Albino; M J Vidal; N S McNutt; C R Shea; V G Prieto; D M Nanus; J M Palmer; N K Hayward
Journal:  Melanoma Res       Date:  1994-02       Impact factor: 3.599

8.  In vitro reconstruction of tumour initiation in a human epithelium.

Authors:  J A Bond; F S Wyllie; J Rowson; A Radulescu; D Wynford-Thomas
Journal:  Oncogene       Date:  1994-01       Impact factor: 9.867

9.  Isolation of a gene encoding a developmentally regulated T cell-specific protein with a guanine nucleotide triphosphate-binding motif.

Authors:  D A Carlow; J Marth; I Clark-Lewis; H S Teh
Journal:  J Immunol       Date:  1995-02-15       Impact factor: 5.422

10.  Stimulation and inhibition of angiogenesis by placental proliferin and proliferin-related protein.

Authors:  D Jackson; O V Volpert; N Bouck; D I Linzer
Journal:  Science       Date:  1994-12-02       Impact factor: 47.728

View more
  20 in total

Review 1.  Growth factors and oncogenes as targets in melanoma: lost in translation?

Authors:  Lawrence Kwong; Lynda Chin; Stephan N Wagner
Journal:  Adv Dermatol       Date:  2007

2.  Guidelines for biomarker testing in metastatic melanoma: a National Consensus of the Spanish Society of Pathology and the Spanish Society of Medical Oncology.

Authors:  S Martín-Algarra; M T Fernández-Figueras; J A López-Martín; A Santos-Briz; A Arance; M D Lozano; A Berrocal; J J Ríos-Martín; E Espinosa; J L Rodríguez-Peralto
Journal:  Clin Transl Oncol       Date:  2013-10-16       Impact factor: 3.405

3.  EGF receptor is required for KRAS-induced pancreatic tumorigenesis.

Authors:  Christine M Ardito; Barbara M Grüner; Kenneth K Takeuchi; Clara Lubeseder-Martellato; Nicole Teichmann; Pawel K Mazur; Kathleen E Delgiorno; Eileen S Carpenter; Christopher J Halbrook; Jason C Hall; Debjani Pal; Thomas Briel; Alexander Herner; Marija Trajkovic-Arsic; Bence Sipos; Geou-Yarh Liou; Peter Storz; Nicole R Murray; David W Threadgill; Maria Sibilia; M Kay Washington; Carole L Wilson; Roland M Schmid; Elaine W Raines; Howard C Crawford; Jens T Siveke
Journal:  Cancer Cell       Date:  2012-09-11       Impact factor: 31.743

4.  The matrikine tenascin-C protects multipotential stromal cells/mesenchymal stem cells from death cytokines such as FasL.

Authors:  Melanie Rodrigues; Cecelia C Yates; Austin Nuschke; Linda Griffith; Alan Wells
Journal:  Tissue Eng Part A       Date:  2013-05-01       Impact factor: 3.845

5.  Cooperative interactions of PTEN deficiency and RAS activation in melanoma metastasis.

Authors:  Minjung Kim
Journal:  Small GTPases       Date:  2010-11

Review 6.  The melanoma revolution: from UV carcinogenesis to a new era in therapeutics.

Authors:  Jennifer A Lo; David E Fisher
Journal:  Science       Date:  2014-11-21       Impact factor: 47.728

7.  Cooperative interactions of PTEN deficiency and RAS activation in melanoma metastasis.

Authors:  C Nogueira; K-H Kim; H Sung; K H T Paraiso; J-H Dannenberg; M Bosenberg; L Chin; M Kim
Journal:  Oncogene       Date:  2010-08-16       Impact factor: 9.867

Review 8.  Melanoma and the tumor microenvironment.

Authors:  Jessie Villanueva; Meenhard Herlyn
Journal:  Curr Oncol Rep       Date:  2008-09       Impact factor: 5.075

Review 9.  NF-kappaB activation in melanoma.

Authors:  Yukiko Ueda; Ann Richmond
Journal:  Pigment Cell Res       Date:  2006-04

Review 10.  Recent advances on skin-resident stem/progenitor cell functions in skin regeneration, aging and cancers and novel anti-aging and cancer therapies.

Authors:  Murielle Mimeault; Surinder K Batra
Journal:  J Cell Mol Med       Date:  2009-09-01       Impact factor: 5.310

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.